Review
Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention
R G WoolfsonDepartment of
Nephrology, Middlesex Hospital, UCLH Trust, Mortimer Street, London
W1N 8AA, UK
Correspondence to: Dr Woolfson r.woolfson@ucl.ac.uk
Submitted 27 March
2000;
Accepted 22 June 2000
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Atherosclerotic renovascular disease (ARVD) is increasingly recognised as an important cause of both chronic and end stage renal failure. These patients tend to do badly on dialysis, which reflects their systemic atherosclerotic burden. In an effort to delay and perhaps prevent their need for renal replacement therapy, some patients are subjected to a variety of medical, radiological and surgical interventions, although evidence for each is sparse. The purpose of this review is to describe the epidemiology and pathophysiology of renal failure in ARVD, discuss the available diagnostic techniques, consider the evidence for benefit from intervention in the context of pathogenesis and finally, identify those gaps in our knowledge which impede the practice of evidence based medicine.
| |
Epidemiology of ARVD |
|---|
The prevalence of ARVD in patients with chronic renal
failure is not known but dialysis registry data provide some
epidemiological information about ARVD among patients who develop end
stage renal failure (ESRF). Over a
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
